Depressive symptoms are a risk factor for all-cause mortality: results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry

被引:68
|
作者
Mols, Floortje [1 ,2 ]
Husson, Olga [1 ,2 ]
Roukema, Jan-Anne [1 ,3 ]
van de Poll-Franse, Lonneke V. [1 ,2 ]
机构
[1] Tilburg Univ, Dept Med Psychol, CoRPS, Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands
[2] Eindhoven Canc Registry, CCCS, Eindhoven, Netherlands
[3] St Elizabeth Hosp, Dept Surg, Tilburg, Netherlands
关键词
Cancer; Depression; Depressive symptoms; Mortality; METASTATIC BREAST-CANCER; HOSPITAL ANXIETY; DISEASE PROGRESSION; SCALE HADS; COMORBIDITY; DIAGNOSIS; DISTRESS; THERAPY; BURDEN;
D O I
10.1007/s11764-013-0286-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The goal of this large prospective population-based study was to examine the association between depressive symptoms and all-cause mortality among cancer survivors up to 10 years post-diagnosis. All currently alive individuals diagnosed with endometrial or colorectal cancer (CRC) between 1998 and 2007 or with lymphoma or multiple myeloma between 1999 and 2008, as registered in the Eindhoven Cancer Registry, received a questionnaire on depressive symptoms (Hospital Anxiety and Depression Scale (HADS)) in 2008 or 2009, respectively; 69 % (n = 3,080) responded. Survival status was obtained from the Central Bureau for Genealogy. Clinically elevated levels of depressive symptoms (HADS cutoff value a parts per thousand yen8) were more prevalent in those who died compared to those who survived (38 vs. 19 %, respectively; p < 0.0001). This was also evident across different types of cancer. After adjustment for independent predictors of all-cause mortality, 1-10-year survivors with depressive symptoms had an increased risk of death (hazard ratio (HR) 2.07; 95 % confidence interval (CI) 1.56-2.74; p < 0.0001), and this was also found among 1-2-year survivors (HR, 2.20; 95 % CI, 1.41-3.43; p < 0.001). Sub-analyses among CRC survivors gave the opportunity to adjust for metastasis and showed that depressive symptoms among 1-10-year CRC survivors and 1-2-year CRC survivors increased the risk of death (HR, 1.88; 95 % CI, 1.24-2.83; p < 0.01 and HR, 2.55; 95 % CI, 1.44-4.51; p < 0.001, respectively). This study showed that patients with depressive symptoms had twofold risk for all-cause mortality, even after adjustment for major clinical predictors. Paying more attention to the recognition and treatment of depressive symptoms seems warranted since depressive symptoms are often underdiagnosed and undertreated in cancer patients.
引用
收藏
页码:484 / 492
页数:9
相关论文
共 50 条
  • [31] β-Blocker use and all-cause mortality of melanoma patients: Results from a population-based Dutch cohort study
    Livingstone, E.
    Hollestein, L. M.
    van Herk-Sukel, M. P. P.
    van de Poll-Franse, L.
    Nijsten, T.
    Schadendorf, D.
    de Vries, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (18) : 3863 - 3871
  • [32] Dyspnea As A Predictor Of All-Cause Mortality In Rural Bangladesh: A Population-Based Prospective Study
    Pesola, G. R.
    Argos, M.
    Parvez, F.
    Islam, T.
    Ahmed, A.
    Rakibuzzaman, M.
    Ahsan, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [33] Clinical and course characteristics of depression and all-cause mortality: A prospective population-based study
    Lasserre, Aurelie M.
    Marti-Soler, Helena
    Strippoli, Marie-Pierre F.
    Vaucher, Julien
    Glaus, Jennifer
    Vandeleur, Caroline L.
    Castelao, Enrique
    Marques-Vidal, Pedro
    Waeber, Gerard
    Vollenweider, Peter
    Preisig, Martin
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 189 : 17 - 24
  • [34] Purine Intake and All-Cause Mortality in Ovarian Cancer: Results from a Prospective Cohort Study
    Du, Zongda
    Gong, Tingting
    Wei, Yifan
    Zheng, Gang
    Zhao, Junqi
    Zou, Bingjie
    Qin, Xue
    Yan, Shi
    Liu, Fanghua
    Xiao, Qian
    Wu, Qijun
    Gao, Song
    Zhao, Yuhong
    NUTRIENTS, 2023, 15 (04)
  • [35] Health Care Use Among Endometrial Cancer Survivors A Study From PROFILES, a Population-Based Survivorship Registry
    Ezendam, Nicole P. M.
    Nicolaije, Kim A. H.
    Boll, Dorry
    Lybeert, Marnix L. M.
    Mols, Floortje
    Pijnenborg, Johanna M. A.
    van de Poll-Franse, Lonneke V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (07) : 1258 - 1265
  • [36] Independent prognostic value of the EORTC QLQ-C30 summary score on all-cause mortality: Results from the population-based PROFILES registry.
    Husson, Olga
    de Rooij, Belle Hadewijch
    Kieffer, Jacobien M.
    Oerlemans, Simone
    Mols, Floortje
    Aaronson, Neil K.
    Van Der Graaf, Winette T. A.
    van de Poll-Franse, Lonneke
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] The association of depressive symptoms with cardiovascular and all-cause mortality in Central and Eastern Europe: Prospective results of the HAPIEE study
    Kozela, Magdalena
    Bobak, Martin
    Besala, Agnieszka
    Micek, Agnieszka
    Kubinova, Ruzena
    Malyutina, Sofia
    Denisova, Diana
    Richards, Marcus
    Pikhart, Hynek
    Peasey, Anne
    Marmot, Michael
    Pajak, Andrzej
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (17) : 1839 - 1847
  • [38] Serum fructosamine and risk of cardiovascular and all-cause mortality: A 24-year prospective population-based study
    Zaccardi, F.
    Kurl, S.
    Pitocco, D.
    Ronkainen, K.
    Laukkanen, J. A.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (02) : 236 - 241
  • [39] Joint association of depressive symptoms and dietary patterns with mortality among US cancer survivors: a population-based study
    Li, Zongyuan
    Yu, Cheng
    Hao, Jianqi
    Shu, Yueli
    Li, Jili
    Zhang, Jian
    Pu, Qiang
    Liu, Lunxu
    BMC CANCER, 2025, 25 (01)
  • [40] Reducing all-cause mortality among patients with psychiatric disorders: a population-based study
    Kisely, Steve
    Preston, Neil
    Xiao, Jianguo
    Lawrence, David
    Louise, Sandra
    Crowe, Elizabeth
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (01) : E50 - E56